Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
diclofenac potassium
- Development stage
- Approved
- Lead developer
- APR Applied Pharma Research
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Diclofenac potassium (PRO-513) is a nonsteroidal anti-inflammatory drug (NSAID) formulated as a buffered soluble powder for oral solution. It is indicated for the acute treatment of migraine attacks with or without aura. The mechanism of action involves inhibition of cyclooxygenase (COX), leading to decreased synthesis of prostaglandins, which are mediators of inflammation and pain. PRO-513 was originally developed by APR Applied Pharma Research and later licensed to ProEthic Pharmaceuticals for North America. Clinical trials demonstrated rapid onset and sustained relief from migraine symptoms, including headache, nausea, photophobia, and phonophobia[1][2][3][4][5].
- Brand names
- Cambia
- Other names
- diclofenac potassiumPRO-513PRO513PRO 513
02
Targets
PGHS-1 (Prostaglandin G/H Synthase 1)
Beyond the preview
Go deeper on diclofenac potassium.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on diclofenac potassium.